Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/SDB-005> ?p ?o }
Showing triples 1 to 62 of
62
with 100 triples per page.
- SDB-005 abstract "SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006. This compound is a potent agonist of the CB1 receptor (Ki = 21 nM) and CB2 receptor (Ki = 140 nM).However SDB-005 was subsequently used as the name for the indazole-3-carboxylate compound mentioned above when it was sold in Europe as a designer drug, and was entered into the EMCDDA synthetic drug database under this name. Consequently, there are now two distinct, yet fairly closely related cannabinoid compounds, which may both be referred to under the code SDB-005.".
- SDB-005 iupacName "naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate".
- SDB-005 thumbnail SDB-005_structure.png?width=300.
- SDB-005 wikiPageID "47090016".
- SDB-005 wikiPageLength "2923".
- SDB-005 wikiPageOutDegree "22".
- SDB-005 wikiPageRevisionID "703380444".
- SDB-005 wikiPageWikiLink 5F-PB-22.
- SDB-005 wikiPageWikiLink 8-Hydroxyquinoline.
- SDB-005 wikiPageWikiLink AM-2201.
- SDB-005 wikiPageWikiLink Agonist.
- SDB-005 wikiPageWikiLink Cannabinoid_receptor_type_1.
- SDB-005 wikiPageWikiLink Cannabinoid_receptor_type_2.
- SDB-005 wikiPageWikiLink Category:Cannabinoids.
- SDB-005 wikiPageWikiLink Category:Designer_drugs.
- SDB-005 wikiPageWikiLink Category:Indazoles.
- SDB-005 wikiPageWikiLink Designer_drug.
- SDB-005 wikiPageWikiLink European_Monitoring_Centre_for_Drugs_and_Drug_Addiction.
- SDB-005 wikiPageWikiLink Indazole.
- SDB-005 wikiPageWikiLink JWH-018.
- SDB-005 wikiPageWikiLink NM-2201.
- SDB-005 wikiPageWikiLink NNE1.
- SDB-005 wikiPageWikiLink Naphthalene.
- SDB-005 wikiPageWikiLink PB-22.
- SDB-005 wikiPageWikiLink QUCHIC.
- SDB-005 wikiPageWikiLink SDB-006.
- SDB-005 wikiPageWikiLink Synthetic_cannabinoids.
- SDB-005 wikiPageWikiLink File:OriginalSDB005_structure.png.
- SDB-005 wikiPageWikiLinkText "SDB-005".
- SDB-005 c "23".
- SDB-005 chemspiderid "30922481".
- SDB-005 h "22".
- SDB-005 iupacName "naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate".
- SDB-005 legalCa "Schedule II".
- SDB-005 molecularWeight "358.17".
- SDB-005 n "2".
- SDB-005 o "2".
- SDB-005 smiles "CCCCCn1ncCOc1cccc2c1cccc2".
- SDB-005 stdinchi "1".
- SDB-005 stdinchikey "JBVNFKZVDLFOAY-UHFFFAOYSA-N".
- SDB-005 wikiPageUsesTemplate Template:Cannabinoid-stub.
- SDB-005 wikiPageUsesTemplate Template:Cannabinoidergics.
- SDB-005 wikiPageUsesTemplate Template:Cannabinoids.
- SDB-005 wikiPageUsesTemplate Template:Clear_left.
- SDB-005 wikiPageUsesTemplate Template:Drugbox.
- SDB-005 wikiPageUsesTemplate Template:Reflist.
- SDB-005 subject Category:Cannabinoids.
- SDB-005 subject Category:Designer_drugs.
- SDB-005 subject Category:Indazoles.
- SDB-005 hypernym Cannabinoid.
- SDB-005 type ChemicalSubstance.
- SDB-005 type Drug.
- SDB-005 type ChemicalObject.
- SDB-005 type Thing.
- SDB-005 type Q8386.
- SDB-005 comment "SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006.".
- SDB-005 label "SDB-005".
- SDB-005 sameAs Q21098933.
- SDB-005 sameAs Q21098933.
- SDB-005 wasDerivedFrom SDB-005?oldid=703380444.
- SDB-005 depiction SDB-005_structure.png.
- SDB-005 isPrimaryTopicOf SDB-005.